Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xencor Inc (XNCR)

Xencor Inc (XNCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,112,995
  • Shares Outstanding, K 61,120
  • Annual Sales, $ 168,340 K
  • Annual Income, $ -126,090 K
  • 60-Month Beta 0.76
  • Price/Sales 6.67
  • Price/Cash Flow N/A
  • Price/Book 1.72
Trade XNCR with:

Options Overview Details

View History
  • Implied Volatility 85.03% ( -13.65%)
  • Historical Volatility 40.27%
  • IV Percentile 83%
  • IV Rank 74.29%
  • IV High 112.55% on 01/25/24
  • IV Low 5.52% on 09/18/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 137
  • Open Int (30-Day) 125

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.76
  • Number of Estimates 5
  • High Estimate -0.50
  • Low Estimate -1.15
  • Prior Year -1.02
  • Growth Rate Est. (year over year) +25.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.94 +1.98%
on 04/19/24
22.87 -19.98%
on 03/25/24
-4.32 (-19.10%)
since 03/22/24
3-Month
17.94 +1.98%
on 04/19/24
26.84 -31.82%
on 02/27/24
-1.43 (-7.25%)
since 01/23/24
52-Week
16.49 +10.98%
on 11/09/23
28.96 -36.81%
on 05/23/23
-10.49 (-36.44%)
since 04/21/23

Most Recent Stories

More News
Xencor: Q4 Earnings Snapshot

Xencor: Q4 Earnings Snapshot

XNCR : 18.71 (+2.75%)
5 Growth Stocks with 66% Upside Potential or More

Here's a closer look at five growth stocks that analysts expect to rally in 2024 as the Fed prepares to pivot to a more dovish policy stance.

GAMB : 8.89 (+0.79%)
SOUN : 4.12 (+8.99%)
XNCR : 18.71 (+2.75%)
RKLB : 3.73 (+3.90%)
GSAT : 1.2900 (+2.38%)
2 Growth Stocks With 35% to 150% Upside in 2024

While all eyes are on AI stocks, there are a few undervalued growth stocks that have the potential to provide investors with massive long-term returns.

ACB : 6.65 (+5.89%)
CGC : 8.53 (+8.66%)
GTBIF : 12.1200 (+0.92%)
$SPX : 5,046.18 (+0.71%)
CRLBF : 2.0000 (+1.01%)
XNCR : 18.71 (+2.75%)
2 Beaten-Down Growth Stocks With 90% or More Upside Potential in 2024

While these stocks have taken a beating this year, Wall Street believes they have major rebound potential in 2024.

XNCR : 18.71 (+2.75%)
TCNNF : 10.8200 (+2.08%)
Xencor: Q3 Earnings Snapshot

Xencor: Q3 Earnings Snapshot

XNCR : 18.71 (+2.75%)
Xencor: Q2 Earnings Snapshot

Xencor: Q2 Earnings Snapshot

XNCR : 18.71 (+2.75%)
Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates

Xencor (XNCR) delivered earnings and revenue surprises of -36% and 1.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

XNCR : 18.71 (+2.75%)
MKGAF : 156.0000 (unch)
Xencor: Q1 Earnings Snapshot

Xencor: Q1 Earnings Snapshot

XNCR : 18.71 (+2.75%)
Xencor Reports First Quarter 2023 Financial Results

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases, today reported financial...

XNCR : 18.71 (+2.75%)
Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release...

XNCR : 18.71 (+2.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

See More

Key Turning Points

3rd Resistance Point 19.13
2nd Resistance Point 18.94
1st Resistance Point 18.57
Last Price 18.71
1st Support Level 18.01
2nd Support Level 17.82
3rd Support Level 17.45

See More

52-Week High 28.96
Fibonacci 61.8% 24.20
Fibonacci 50% 22.72
Fibonacci 38.2% 21.25
Last Price 18.71
52-Week Low 16.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar